United Therapeutics – Value – NASDAQ
|
United Therapeutics – Value
NASDAQ United Therapeutics Corporation ( UTHR ) performed above expectations in the first half of 2012 and is positioned to continue performing well through the remainder of the year. This Zacks #1 Rank (Strong Buy) biotechnology company is well-positioned to … |
